Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus in children with tuberous sclerosis complex and neuropsychological deficits (RAPIT trial)
NL-OMON39487Phase 2Active, not recruiting
- Sponsor
- Erasmus MC
- Start
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in tuberous sclerosis complex (TSC) comparing Everolimus with Placebo (2 arms). Primary endpoint: Effect of everolimus on cognitive development. Started Nov 2012; status: active, not recruiting.
02
Drugs
everolimus
03
Conditions
tuberous sclerosis complex (TSC)
Beyond the preview
Go deeper on NL-OMON39487.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON39487.